Jenkem Technology Enrolls First Subject for Phase III Trial of Lung Cancer Drug; Shares Jump 13%

MT Newswires · Sep 30 13:16

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

Jenkem Technology Enrolls First Subject for Phase III Trial of Lung Cancer Drug; Shares Jump 13%

Risk Disclaimer